azomycin has been researched along with Experimental Neoplasms in 193 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 128 (66.32) | 18.7374 |
1990's | 33 (17.10) | 18.2507 |
2000's | 14 (7.25) | 29.6817 |
2010's | 16 (8.29) | 24.3611 |
2020's | 2 (1.04) | 2.80 |
Authors | Studies |
---|---|
Jans, HS; Kumar, P; Wang, M; Wiebe, LI; Wuest, M; Yang, J | 1 |
Kumar, P; Mannan, RH; McEwan, AJ; Wiebe, LI; Xia, H; Zhang, Z | 1 |
Chapman, JD; Iyer, RV; Kim, E; Schneider, RF | 1 |
Minchinton, AI; Stratford, MR | 1 |
Brender, JR; Chandramouli, GVR; Kishimoto, S; Krishna, MC; Mitchell, JB; Saida, Y; Yamamoto, K | 1 |
Cai, K; Chen, Y; He, H; Sun, W; Yin, L; Zhu, R | 1 |
Ager, C; Ai, M; Balasubramanyam, S; Bartkowiak, T; Budhani, P; Curran, MA; Jaiswal, AR; Jayaprakash, P; Li, N; Liu, A; Nicholas, C; Ning, J; Shah, K; Sheng, J; Sun, Y; Wang, G; Zal, A; Zal, T | 1 |
Hua, L; Ju, H; Li, Y; Liu, H; Mao, H; Wang, Z; Xie, Y; Yu, R; Zhao, C; Zhao, L | 1 |
Dietz, C; Erfanzadeh, M; Smith, MB; Wang, L; Yao, X; Zhou, F; Zhu, Q | 1 |
McEwan, AJ; Mercer, JR; Wiebe, LI | 1 |
Belloli, S; Di Grigoli, G; Fazio, F; Masiello, V; Monterisi, C; Moresco, RM; Picchio, M; Sanvito, F; Valtorta, S | 1 |
Saggar, JK; Tannock, IF | 1 |
Chu, T; Lin, X; Luo, R; Luo, Z; Wang, Y; Yang, Z; Zhu, H | 1 |
Feng, F; Higashino, K; Kuge, Y; Masaki, Y; Numata, Y; Shimizu, Y; Yoshioka, T; Zhao, S | 1 |
Cheguillaume, A; De Bast, M; de Groot, T; Gillart, J; Grégoire, V; Haustermans, K; Labar, D; Mahy, P | 1 |
Busk, M; Horsman, MR; Overgaard, J | 1 |
Cui, P; Dai, M; Han, J; Li, H; Liu, Q; Xiu, R; Yu, M; Zhang, J | 1 |
Cecic, IK; Erler, JT; Felsher, D; Giaccia, AJ; Graves, EE; Le, QT; Sayles, L; Sweet-Cordero, A; Tran, PT; Vilalta, M | 1 |
Alsner, J; Busk, M; Horsman, MR; Jakobsen, S; Overgaard, J; Sørensen, BS; Toustrup, K | 1 |
Bussink, J; Dubois, LJ; Janssen, MH; Kolb, HC; Lambin, P; Lieuwes, NG; Ollers, MC; Peeters, WJ; van der Kogel, A; van Dongen, GA; Walsh, JC; Windhorst, AD | 1 |
Bukala, D; Cay, F; Judenhofer, MS; Kneilling, M; Machulla, HJ; Maier, FC; Pichler, BJ; Reischl, G; Röcken, M; Schmid, A | 1 |
Ahluwalia, D; Ammons, WS; Curd, JG; Duan, JX; Ferraro, D; Hart, CP; Liu, Q; Matteucci, MD; Sun, JD; Wang, J; Wang, Y | 1 |
Bol, A; Gallez, B; Grégoire, V; Jordan, B; Labar, D; Magat, J; Mignion, L; Tran, LB | 1 |
Fujii, H; Inoue, K; Kizaka-Kondoh, S; Moriyama, N; Mutou, Y; Saji, H; Ueda, M; Umeda, IO; Yamaguchi, M | 1 |
Grimshaw, R; Honess, DJ; Maxwell, RJ; Raynaud, F; Seddon, BM; Tozer, GM; Workman, P | 1 |
Adomat, H; Bowden, M; Dragowska, W; Gleave, M; Koch, CJ; Skov, K; Woo, J; Yapp, DT | 1 |
Banerjee, S; Mallia, MB; Mathur, A; Sarma, HD; Subramanian, S; Venkatesh, M | 1 |
Baumann, M; Bergmann, R; Beuthien-Baumann, B; Brüchner, K; Dörfler, A; Eicheler, W; Hessel, F; Krause, M; Menegakis, A; Schütze, C; van den Hoff, J; Wüllrich, K; Yaromina, A; Zhou, X; Zips, D | 1 |
Beck, R; Haubner, R; Johnson, TD; Machulla, HJ; Picchio, M; Piert, M; Reischl, G; Schwaiger, M; Seidl, S; Wester, HJ | 1 |
Varghese, AJ; Whitmore, GF | 1 |
Handa, H; Oda, Y; Ono, K; Otsuka, S; Suda, K; Takeuchi, J; Yamashita, J; Yumitori, K | 1 |
Chaplin, DJ; Jinks, S; Millar, BC | 1 |
Brown, JM; Hazlehurst, JL; Hirst, DG | 4 |
Abe, M; Nishidai, T; Ono, K; Shibamoto, Y; Takahashi, M | 1 |
Brown, JM | 4 |
Kehrberg, G; Moldenhauer, H; Rose, H; Saul, G; Wolf, G | 1 |
Brown, JM; Yu, NY | 4 |
Blanke, G; Luscher, G; Streffer, C; Tamulevicius, P | 1 |
Brown, JM; Hazlehurst, JL; Hirst, DG; Horsman, MR | 1 |
Denekamp, J; Fowler, JF; Williams, MV | 1 |
Phillips, TL | 2 |
Brustad, T; Pettersen, EO; Rofstad, EK | 1 |
Brustad, T; Rofstad, EK | 3 |
Ando, K; Furukawa, S; Hiraoka, T; Kanai, T; Kawachi, K; Koike, S; Majima, H | 1 |
Denekamp, J; Rojas, A; Stewart, FA | 1 |
Hunter, N; Ito, H; Milas, L | 1 |
Beach, JL; Grigsby, PW; Mendiondo, OA | 1 |
Adams, GE; Hardy, C; Hoe, S; O'Neill, P; Sheldon, PW; Stratford, IJ | 1 |
Brown, DM; Brown, JM; Lee, WW; Yu, NY | 1 |
Owen, LN; Twentyman, PR; Walton, MI; White, RA; Workman, P | 1 |
de Ronde, J; Hinchliffe, M; McNally, NJ | 1 |
Adams, GE; Ahmed, I; Chaplin, DJ; Sheldon, PW | 1 |
Denekamp, J; Middleton, RW; Minchinton, AI; Rojas, A; Smith, KA; Soranson, JA | 1 |
Chapman, JD; Jette, DC; Wiebe, LI | 1 |
Chapman, JD; Garrecht, BM | 1 |
Brown, DM; Brown, JM; Eifel, PJ; Lee, WW | 1 |
Gibson, P; Sheldon, PW | 1 |
Dembs, NL; Mulcahy, RT; Ublacker, GA | 1 |
Twentyman, PR; Workman, P | 1 |
Lee, FY; Workman, P | 1 |
Blasberg, R; Fenstermacher, J; Horowitz, M; Kornblith, P; Molnar, P; Pleasants, R; Strong, J | 1 |
Csejtey, J; Landahl, HD; Levin, VA; Patlak, CS; Wright, DC | 1 |
Afzal, SM; Curtis, SB; Howard, J; Lyman, JT; Parr, SS; Tenforde, TS | 1 |
Clutterbuck, RD; McElwain, TJ; Millar, JL | 1 |
Chapman, JD; Franko, AJ | 1 |
Freauff, S; Krohn, KA; Rasey, JS | 1 |
Adams, GE; Batten, EL; Sheldon, PW | 1 |
Breur, K; Haveman, J; van den Hoeven, H; van der Schueren, E; Wondergem, J | 1 |
Abratt, RP | 1 |
Glatte, P; Haedecke, U; Osieka, R; Schmidt, CG | 1 |
Aritake, S; Sakamoto, K | 1 |
Courtenay, VD; Mills, J; Peacock, JH; Rose, CM; Spooner, D; Stephens, TC | 1 |
Hampel, N; Persky, L | 1 |
Barratt, GM; Wills, ED | 1 |
Astor, M; Biaglow, JE; Hall, EJ; Varnes, ME | 1 |
Bleehen, NM; Morgan, JE | 1 |
Denekamp, J; Hirst, DG; Stewart, FA; Terry, NH | 1 |
Arcangeli, G; Barocas, A; Mauro, F; Nervi, C; Spanò, M; Tabocchini, A | 1 |
Conroy, PJ; Passalacqua, W; Penney, DP; Sutherland, RM; Von Burg, R | 1 |
Bleehen, NM; Honess, DJ; Morgan, JE; Workman, P | 1 |
Bareham, BJ; Reich, KA; Sutherland, RM | 1 |
Gueulette, J; Guichard, M; Malaise, EP; Octave-Prignot, M; Wambersie, A | 1 |
Denekamp, J | 2 |
Workman, P | 3 |
Allalunis, MJ; Meeker, BE; Pedersen, JE; Turner, AR; Urtasun, RC | 1 |
Catane, R; Clement, JJ; Gorman, MS; Johnson, RK; Wodinsky, I | 1 |
Cherif, A; Gretzer, MB; Kim, EE; Li, C; Podoloff, DA; Wallace, S; Yang, DJ | 1 |
Abe, M; Oya, N; Sasai, K; Shibamoto, Y; Shibata, T; Sugiyama, T | 1 |
Streffer, C; Tamulevicius, P | 1 |
Cline, JM; McEntee, MC; Raleigh, JA; Thrall, DE | 1 |
Bremner, JC | 1 |
el Gamoussi, R; Guichard, M; Prade, M; Stratford, IJ; Threadgill, MD | 1 |
Miyata, Y; Mori, T; Murayama, C; Nishio, A; Sakaguchi, M; Sato, C; Shoji, T; Suzuki, A; Suzuki, T; Tanabe, Y | 1 |
Hodgkiss, RJ; Webster, L; Wilson, GD | 2 |
Abe, M; Hiraoka, M; Murata, R; Oya, N; Sasai, K; Shibamoto, Y; Shibata, T; Takagi, T | 1 |
Ballinger, JR; Kee, JW; Rauth, AM | 1 |
Chapman, JD; Coia, LR; Engelhardt, EL; Fenning, MC; Schneider, RF; Stobbe, CC | 1 |
Aboagye, EO; Graham, MA; Griffiths, JR; Horsman, MR; Kelson, AB; Lewis, AD; Maxwell, RJ; Tracy, M; Workman, P | 1 |
Adams, GE; Butler, SA; Cole, S; Stratford, IJ; Williams, C; Wood, PJ | 1 |
Hori, H; Inayama, S; Inomata, T; Kasai, S; Kuwasaka, H; Nagasawa, H; Nishioka, A; Ogawa, Y; Oshodani, T; Yoshida, S | 1 |
Antoku, S; Ichiya, Y; Maeda, M; Masuda, K; Oka, H; Yamamoto, F | 1 |
Ballinger, JR; Duncan, J; Melo, T; Rauth, AM | 1 |
Kumar, P; Lee, HC; McEwan, AJ; Mercer, JR; Wiebe, LI | 1 |
Busch, TM; Evans, SM; Hahn, SM; Koch, CJ | 1 |
O'Hara, JA; Paulsen, KD; Pogue, BW; Swartz, HM; Wilmot, CM | 1 |
Ando, K; Aoki, M; Furusawa, Y; Kuwabara, Y; Maeda, M; Masuda, K; Sasaki, S; Yamamoto, F | 1 |
Adams, GE; Dische, S; Fowler, JF; Thomlinson, RH | 1 |
Kligerman, MM; Peterson, DF; West, G; Yuhas, JM; Yurconic, M | 1 |
Chapman, JD; Urtasun, RC | 1 |
Denekamp, J; Flockhart, IR; McNally, NJ; Sheldon, P; Stewart, FA | 1 |
Bleehen, NM; Honess, DJ; Morgan, JE | 1 |
Bicknell, RB; Brown, JM; Cory, MJ; Taylor, DL; Yu, NY | 1 |
Peckham, MJ; Stanley, JA; Steel, GG | 1 |
Courtenay, VD; Smith, IE; Steel, GG | 1 |
Fowler, JF; Sheldon, PW | 1 |
Denekamp, J; Stewart, FA | 1 |
Wardman, P | 2 |
Bugden, RD; Peckham, MJ; Pedersen, JE; Smith, MR | 1 |
de Langen-Omri, F; Guichard, M; Malaise, EP | 1 |
Brown, JM; Workman, P; Yu, NY | 1 |
Suwiński, J; Watras, J; Wideł, M | 1 |
Paciga, JE; Rauth, AM | 1 |
Hofer, KG; Hofer, MG; Ieracitano, J; McLaughlin, WH | 1 |
Fowler, JF; Hill, SA | 1 |
Hill, SA; Sheldon, PW | 2 |
Adams, GE; Denekamp, J; Fowler, JF | 1 |
Adams, GE; Fowler, JF | 1 |
Chapman, JD; Mannan, RH; Mercer, JR; Somayaji, VV; Wiebe, LI | 1 |
Hori, H; Inayama, S; Nagasawa, H; Nakajima, T; Onoyama, Y; Tada, T | 1 |
Miyata, Y; Mori, T; Murayama, C; Sakaguchi, M; Sato, C; Shoji, T; Suzuki, A; Suzuki, T; Tanabe, Y | 1 |
Moore, SK; Wallen, CA; Wheeler, KT | 1 |
Adams, GE; Bremner, JC; Cole, S; Edwards, HS; Stratford, IJ | 1 |
Chaplin, DJ; Horsman, MR | 1 |
Anderson, RF; Brown, JM; Denny, WA; Phil, D; Roberts, PB; Wilson, WR | 1 |
Abe, M; Ito, T; Kagiya, VT; Nishimoto, S; Sasai, K; Wang, J | 1 |
Brown, JM; Cribbs, R; Hirst, VK; Luu, YH; Stone, HB | 1 |
Hisanaga, Y; Kagiya, T; Kitakabu, Y; Nishimoto, S; Sasai, K; Shibamoto, Y; Shimokawa, K; Takahashi, M; Wang, J; Zhou, L | 1 |
Chapman, JD; Lee, J; Mannan, RH; Mercer, JR; Somayaji, VV; Wiebe, LI | 1 |
Jin, GY; Li, SJ; Moulder, JE; Raleigh, JA | 1 |
Hodgkiss, RJ; Jones, G; Long, A; Parrick, J; Smith, KA; Stratford, MR; Wilson, GD | 1 |
Jin, GY; Li, SJ; Moulder, JE | 1 |
Wallen, CA; Wheeler, KT; Wong, KH | 1 |
Hirst, DG | 1 |
Coldwell, DM; Coldwell, SG; Huff, J; Marcellus, H | 1 |
Bonnay, M; Guichard, M; Lespinasse, F; Malaise, EP; Thomas, C | 1 |
Howes, AE; Kramer, RA; Montoya, VP; Soble, M | 1 |
Mori, T | 1 |
Miyata, Y; Mori, T; Murayama, C; Sakaguchi, M; Suzuki, A; Suzuki, T; Tanabe, Y; Tanaka, N | 1 |
Mori, T; Murayama, C | 2 |
Abe, M; Hisanaga, Y; Kagiya, T; Nishimoto, S; Sasai, K; Shibamoto, Y; Shimokawa, K; Takahashi, M; Wang, J; Zhou, L | 1 |
Griffiths, JR; Maxwell, RJ; Workman, P | 1 |
Bleehen, NM; Walton, MI; Workman, P | 1 |
Luscher, G; Streffer, C; Tamulevicius, P | 1 |
Chapman, JD; Kanclerz, A | 1 |
Adams, GE; Stratford, IJ | 1 |
Hill, RP | 1 |
Lam, KN; Luu, YH; Stone, HB | 1 |
Biscay, P; Guichard, M; Lespinasse, F; Malaise, EP | 1 |
Bleehen, NM; Honess, DJ; Ward, R; Wasserman, TH; Workman, P | 1 |
Salet, C | 1 |
Walton, MI; Workman, P | 1 |
Baran, LA; Gol'dshmid, BIa; Kurliand, VA; Nonko, VD; Rudakov, NP | 1 |
Abe, M; Kagiya, T; Kimura, R; Nishidai, T; Nishimoto, S; Ono, K; Sakano, K; Shibamoto, Y | 1 |
Allen, PS; Franko, AJ; Lunt, JA; Raleigh, JA; Treiber, EO | 1 |
Agrawal, KC; Rockwell, S; Rupp, WD | 1 |
Abe, M; Hori, H; Inayana, S; Ono, K; Shibamoto, Y; Shibata, T; Takahashi, M | 1 |
Mulcahy, RT; Siemann, DW | 1 |
Chapman, JD; Flanagan, RJ; Jette, DC; Lee, J; Wiebe, LI | 1 |
Born, JL; Franko, AJ; Koch, CJ; Raleigh, JA | 1 |
Blasberg, R; Fenstermacher, J; Horowitz, M; Molnar, P; Owens, E; Patlak, C; Strong, J | 1 |
Chin, L; Grunbaum, Z; Krohn, K; Nelson, N; Rasey, JS | 1 |
Bauer, K; Conroy, PJ; Grunbaum, Z; Krohn, KA; Rasey, JS; Sutherland, RM | 1 |
Bryan, GT; Cohen, SM; Crovetti, AJ; Ertürk, E; Von Esch, AM | 1 |
13 review(s) available for azomycin and Experimental Neoplasms
Article | Year |
---|---|
[Intensification of cytostatic action by radiosensitizers--a review of the present status of chemosensitization].
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Chlorambucil; Cisplatin; Cricetinae; Cyclophosphamide; Doxorubicin; Etanidazole; Lomustine; Melphalan; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1984 |
Sensitizers and protectors in clinical oncology.
Topics: Alkylating Agents; Amifostine; Animals; Drug Synergism; Humans; Mice; Misonidazole; Neoplasms; Neoplasms, Experimental; Nitroimidazoles; Organothiophosphorus Compounds; Radiation-Protective Agents; Radiation-Sensitizing Agents | 1981 |
Assessing the bioreductive effectiveness of the nitroimidazole RSU1069 and its prodrug RB6145: with particular reference to in vivo methods of evaluation.
Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Cell Line; Cell Survival; Humans; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Oxidation-Reduction; Prodrugs; Radiation-Sensitizing Agents | 1993 |
Radiation sensitizers.
Topics: Animals; Antineoplastic Agents; Bromodeoxycytidine; Bromodeoxyuridine; Carcinoma; Deoxyuridine; Dogs; Dose-Response Relationship, Radiation; Floxuridine; Humans; Hypoxia; Idoxuridine; Lung Neoplasms; Methotrexate; Metronidazole; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Research; Sarcoma, Experimental; Skin | 1976 |
Chemical modification of radiation effects.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Cell Survival; Cysteamine; DNA; Drug Evaluation; Drug Interactions; Humans; Hypoxia; Metronidazole; Neoplasms; Neoplasms, Experimental; Nitroimidazoles; Radiation Effects; Radiation-Protective Agents; Radiation-Sensitizing Agents | 1977 |
The use of nitroaromatic compounds as hypoxic cell radiosensitizers.
Topics: Acetophenones; Animals; Cells, Cultured; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Neoplasms, Experimental; Nitro Compounds; Nitrobenzenes; Nitrofurans; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Serratia marcescens; Structure-Activity Relationship | 1977 |
[Radiosensitizer: hypoxic cell radiosensitizer].
Topics: Animals; DNA; Dogs; Etanidazole; Hydroxamic Acids; Hydroxylation; Intercalating Agents; Lethal Dose 50; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation Tolerance; Radiation-Sensitizing Agents; Thymine | 1989 |
Micropharmacokinetics of chemical modifiers.
Topics: Animals; Cells, Cultured; Flow Cytometry; Humans; Magnetic Resonance Spectroscopy; Mice; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1989 |
[Present status of radiation sensitizers--hypoxic cell radiosensitizer].
Topics: Animals; Hydroxamic Acids; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1989 |
Hypoxia-mediated nitro-heterocyclic drugs in the radio- and chemotherapy of cancer. An overview.
Topics: Alkylating Agents; Animals; Cell Survival; Drug Synergism; Etanidazole; Hypoxia; Misonidazole; Neoplasms, Experimental; Nitrofurans; Nitrofurazone; Nitroimidazoles; Oxidation-Reduction; Radiation-Sensitizing Agents; Structure-Activity Relationship | 1986 |
Sensitizers and radiation dose fractionation: results and interpretations.
Topics: Animals; Combined Modality Therapy; Etanidazole; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Radiotherapy Dosage | 1986 |
Sensitizers and protectors in radiotherapy.
Topics: Amifostine; Animals; Aziridines; Clinical Trials as Topic; Drug Evaluation; Etanidazole; Glutathione; Humans; Misonidazole; Neoplasms; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Protective Agents; Radiation-Sensitizing Agents; Radiotherapy | 1985 |
Hematoporphyrin and hematoporphyrin-derivative photosensitization of mitochondria.
Topics: Adenosine Triphosphatases; Animals; Biological Transport, Active; Calcium; Cell Line; Electron Transport Complex IV; Hematoporphyrin Derivative; Hematoporphyrins; Lasers; Light; Mitochondria; Mitochondria, Liver; Neoplasms, Experimental; Nitroimidazoles; Oxidative Phosphorylation; Oxygen; Oxygen Consumption; Photochemistry; Rats; Succinate Dehydrogenase | 1986 |
3 trial(s) available for azomycin and Experimental Neoplasms
Article | Year |
---|---|
Dose-response relationships for human tumors: implications for clinical trials of dose modifying agents.
Topics: Animals; Clinical Trials as Topic; Dose-Response Relationship, Radiation; Etanidazole; Humans; Mice; Misonidazole; Neoplasms; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents | 1984 |
Hypoxic cell sensitisers in radiotherapy.
Topics: Animals; Clinical Trials as Topic; Drug Evaluation; Drug Evaluation, Preclinical; Humans; Hypoxia; In Vitro Techniques; Mice; Neoplasms; Neoplasms, Experimental; Nitroimidazoles; Oxygen Consumption; Radiation-Sensitizing Agents; Radiotherapy Dosage | 1976 |
Sensitizers and protectors in radiotherapy.
Topics: Amifostine; Animals; Aziridines; Clinical Trials as Topic; Drug Evaluation; Etanidazole; Glutathione; Humans; Misonidazole; Neoplasms; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Protective Agents; Radiation-Sensitizing Agents; Radiotherapy | 1985 |
178 other study(ies) available for azomycin and Experimental Neoplasms
Article | Year |
---|---|
In vitro and in vivo evaluation of [(18)F]F-GAZ, a novel oxygen-mimetic azomycin-glucose conjugate, for imaging hypoxic tumor.
Topics: Animals; Biomimetic Materials; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
[99mTc]Technetium labelled PnAo-azomycin glucuronides: a novel class of imaging markers of tissue hypoxia.
Topics: Animals; Glucuronides; HeLa Cells; Humans; Hypoxia; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Nitroimidazoles; Organotechnetium Compounds; Oximes; Radionuclide Imaging; Radiopharmaceuticals; Tumor Cells, Cultured | 2002 |
A dual hypoxic marker technique for measuring oxygenation change within individual tumors.
Topics: Animals; Biomarkers; Cell Hypoxia; Iodine Radioisotopes; Male; Mice; Mice, SCID; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Rats; Rats, Inbred F344 | 1998 |
A comparison of tumor and normal tissue levels of acidic, basic and neutral 2-nitroimidazole radiosensitizers in mice.
Topics: Animals; Etanidazole; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Tissue Distribution | 1986 |
Hypoxia-Activated Prodrug Evofosfamide Treatment in Pancreatic Ductal Adenocarcinoma Xenografts Alters the Tumor Redox Status to Potentiate Radiotherapy.
Topics: Animals; Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Cell Hypoxia; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Humans; Mice; Neoplasms, Experimental; Nitroimidazoles; Oxidation-Reduction; Pancreatic Neoplasms; Phosphoramide Mustards; Prodrugs | 2021 |
Selective cancer treatment via photodynamic sensitization of hypoxia-responsive drug delivery.
Topics: Animals; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Female; Hyaluronic Acid; Hypoxia; Mice, Inbred C57BL; Micelles; Nanoparticles; Neoplasms, Experimental; Nitroimidazoles; Photoacoustic Techniques; Photochemotherapy; Polyethyleneimine; Tissue Distribution | 2018 |
Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy.
Topics: Adenocarcinoma; Animals; Cell Hypoxia; Cell Line, Tumor; Immunotherapy; Male; Mice; Mice, Knockout; Neoplasm Proteins; Neoplasms, Experimental; Nitroimidazoles; Phosphoramide Mustards; Prostatic Neoplasms; T-Lymphocytes | 2018 |
Design of Tumor Microenvironment-Responsive Drug-Drug Micelle for Cancer Radiochemotherapy.
Topics: Animals; Cell Line, Tumor; Chemoradiotherapy; Doxorubicin; Ferrous Compounds; Humans; Hyaluronic Acid; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Neoplasms, Experimental; Nitroimidazoles; Tumor Hypoxia; Tumor Microenvironment | 2018 |
Treasure hunt for peptides with undefined chemical modifications: Proteomics identification of differential albumin adducts of 2-nitroimidazole-indocyanine green in hypoxic tumor.
Topics: Albumins; Animals; Indocyanine Green; Mice; Neoplasms, Experimental; Nitroimidazoles; Optical Imaging; Peptides; Proteome; Proteomics; Tumor Hypoxia | 2020 |
[131I]IAZA as a molecular radiotherapeutic (MRT) drug: wash-out with cold IAZA accelerates clearance in a murine tumor model.
Topics: Animals; Cold Temperature; Healthy Volunteers; Humans; Iodine Radioisotopes; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Nitroimidazoles; Radiopharmaceuticals; Tissue Distribution | 2013 |
Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.
Topics: Animals; Cell Line, Tumor; Coordination Complexes; Copper Radioisotopes; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Nitroimidazoles; Organ Specificity; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thiosemicarbazones; Tissue Distribution | 2013 |
Chemotherapy Rescues Hypoxic Tumor Cells and Induces Their Reoxygenation and Repopulation-An Effect That Is Inhibited by the Hypoxia-Activated Prodrug TH-302.
Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Docetaxel; Doxorubicin; Female; Humans; Immunohistochemistry; Mice; Mice, Nude; Neoplasms, Experimental; Nitroimidazoles; Phosphoramide Mustards; Prodrugs; Taxoids; Xenograft Model Antitumor Assays | 2015 |
Synthesis and radiolabeling of (64)Cu-labeled 2-nitroimidazole derivative (64)Cu-BMS2P2 for hypoxia imaging.
Topics: Animals; Cell Hypoxia; Coordination Complexes; Copper Radioisotopes; Isotope Labeling; Lung Neoplasms; Mice; Molecular Imaging; Molecular Structure; Neoplasms, Experimental; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Imaging Mass Spectrometry Revealed the Accumulation Characteristics of the 2-Nitroimidazole-Based Agent "Pimonidazole" in Hypoxia.
Topics: Animals; Cell Hypoxia; Glutathione; Humans; Male; Mass Spectrometry; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Nitroimidazoles | 2016 |
Comparative pharmacokinetics, biodistribution, metabolism and hypoxia-dependent uptake of [18F]-EF3 and [18F]-MISO in rodent tumor models.
Topics: Animals; Fluorine Radioisotopes; Hypoxia; Male; Mice; Mice, Inbred C3H; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Radiopharmaceuticals; Tissue Distribution | 2008 |
Resolution in PET hypoxia imaging: voxel size matters.
Topics: Animals; Carcinoma, Squamous Cell; Cell Hypoxia; Mice; Mice, Nude; Microscopy, Fluorescence; Necrosis; Neoplasms, Experimental; Nitroimidazoles; Positron-Emission Tomography | 2008 |
Effect of artificial oxygen carrier with chemotherapy on tumor hypoxia and neovascularization.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cricetinae; HeLa Cells; Hemoglobins; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Mesocricetus; Microvessels; Neoplasms, Experimental; Neovascularization, Pathologic; Nitroimidazoles; Oxygen; Oxygen Inhalation Therapy; Polyethylene Glycols; Tumor Burden | 2008 |
Hypoxia in models of lung cancer: implications for targeted therapeutics.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Electrodes; Histones; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Neoplasms, Experimental; Nitrogen Mustard Compounds; Nitroimidazoles; Oxygen; Positron-Emission Tomography; Proto-Oncogene Proteins c-myc; ras Proteins | 2010 |
In vivo identification and specificity assessment of mRNA markers of hypoxia in human and mouse tumors.
Topics: Animals; Biomarkers, Tumor; Carbonic Anhydrases; Cell Line, Tumor; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Hypoxia; Mice; Mice, Inbred C3H; Mice, Inbred Strains; Mice, Nude; Neoplasms, Experimental; Nitroimidazoles; Positron-Emission Tomography; Protein-Lysine 6-Oxidase; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transplantation, Heterologous | 2011 |
Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging.
Topics: Animals; Biomarkers; Cell Hypoxia; Fluorine Radioisotopes; Imidazoles; Male; Neoplasms, Experimental; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Triazoles | 2011 |
Significant impact of different oxygen breathing conditions on noninvasive in vivo tumor-hypoxia imaging using [¹⁸F]-fluoro-azomycinarabino-furanoside ([¹⁸F]FAZA).
Topics: Animals; Cell Hypoxia; Diagnostic Imaging; Fluorine Radioisotopes; Hypoxia; Image Processing, Computer-Assisted; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Respiration; Ribose | 2011 |
Selective tumor hypoxia targeting by hypoxia-activated prodrug TH-302 inhibits tumor growth in preclinical models of cancer.
Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Cell Line, Tumor; Female; Humans; Immunohistochemistry; Mice; Mice, SCID; Neoplasms, Experimental; Neovascularization, Pathologic; Nitroimidazoles; Phosphoramide Mustards; Prodrugs; Xenograft Model Antitumor Assays | 2012 |
Hypoxia imaging with the nitroimidazole 18F-FAZA PET tracer: a comparison with OxyLite, EPR oximetry and 19F-MRI relaxometry.
Topics: Animals; Cell Hypoxia; Fluorine Radioisotopes; Magnetic Resonance Imaging; Male; Neoplasms, Experimental; Nitroimidazoles; Oximetry; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rhabdomyosarcoma | 2012 |
In vivo visualization of heterogeneous intratumoral distribution of hypoxia-inducible factor-1α activity by the fusion of high-resolution SPECT and morphological imaging tests.
Topics: Animals; Female; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Iodine Radioisotopes; Magnetic Resonance Imaging; Mice; Mice, Inbred C3H; Molecular Imaging; Molecular Probes; Neoplasms, Experimental; Nitroimidazoles; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2012 |
Validation of the fluorinated 2-nitroimidazole SR-4554 as a noninvasive hypoxia marker detected by magnetic resonance spectroscopy.
Topics: Animals; Biomarkers, Tumor; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; Female; Fluorine Radioisotopes; Hypoxia; Magnetic Resonance Spectroscopy; Mice; Mice, SCID; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Polarography; Rats; Tissue Distribution | 2002 |
Hypoxia in the androgen-dependent Shionogi model for prostate cancer at three stages.
Topics: Androgens; Animals; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Flow Cytometry; Hypoxia; Image Cytometry; Male; Mammary Neoplasms, Animal; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Nitroimidazoles; Prognosis; Prostatic Neoplasms; Protein Binding; Time Factors; Tumor Burden | 2004 |
A novel [99mTc[triple bond]N]2+ complex of metronidazole xanthate as a potential agent for targeting hypoxia.
Topics: Animals; Hypoxia; Imidazoles; Ligands; Metronidazole; Mice; Molecular Structure; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Structure-Activity Relationship; Time Factors; Tissue Distribution | 2005 |
Experimental evaluation of functional imaging for radiotherapy.
Topics: Animals; Biomarkers, Tumor; Dose Fractionation, Radiation; Fluorodeoxyglucose F18; Humans; Mice; Mice, Nude; Neoplasms, Experimental; Neoplastic Stem Cells; Nitroimidazoles; Positron-Emission Tomography; Proportional Hazards Models; Radiation-Sensitizing Agents; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage; Xenograft Model Antitumor Assays | 2007 |
Intratumoral spatial distribution of hypoxia and angiogenesis assessed by 18F-FAZA and 125I-Gluco-RGD autoradiography.
Topics: Animals; Autoradiography; Cell Hypoxia; Female; Fluorine Radioisotopes; Glucosides; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Iodine Radioisotopes; Mice; Neoplasms, Experimental; Neovascularization, Pathologic; Nitroimidazoles; Oligopeptides; Radionuclide Imaging | 2008 |
Binding to cellular macromolecules as a possible mechanism for the cytotoxicity of misonidazole.
Topics: Ammonium Chloride; Animals; Cricetinae; Cricetulus; DNA; Female; Injections, Intraperitoneal; Macromolecular Substances; Mice; Mice, Inbred C3H; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Ovary; Oxidation-Reduction; RNA; Serum Albumin, Bovine; Zinc | 1980 |
[Radiosensitizing effect of misonidazole on intracranially transplanted tumors in mice and its clinical application (author's transl)].
Topics: Adult; Aged; Animals; Brain Neoplasms; Cobalt Radioisotopes; Female; Glioma; Humans; Male; Mice; Mice, Inbred C57BL; Middle Aged; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Radiotherapy Dosage | 1982 |
Studies on the protection against misonidazole-induced toxicity by antiinflammatory agents.
Topics: Animals; Cell Line; Cell Survival; Cricetinae; Cricetulus; Dexamethasone; Female; Flurbiprofen; Lung; Lung Neoplasms; Mice; Mice, Inbred Strains; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Phospholipases; Phospholipases A; Propionates | 1983 |
Sensitization of normal and malignant tissue to cyclophosphamide by nitroimidazoles with different partition coefficients.
Topics: Animals; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Etanidazole; Mice; Mice, Inbred C3H; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents | 1984 |
[Recent advances in hypoxic cell radiosensitizer].
Topics: Animals; Cells, Cultured; Etanidazole; Maleates; Mice; Mice, Inbred C3H; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Oxygen Consumption; Radiation-Sensitizing Agents | 1983 |
Clinical trials of radiosensitizers: what should we expect?
Topics: Animals; Cell Line; Cell Survival; Cricetinae; Dogs; Dose-Response Relationship, Drug; Drug Evaluation; Drug Evaluation, Preclinical; Etanidazole; Humans; Kinetics; Lethal Dose 50; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents | 1984 |
Radiosensitization of hypoxic cells in vivo by SR 2508 at low radiation doses: a preliminary report.
Topics: Animals; Combined Modality Therapy; Dose-Response Relationship, Radiation; Etanidazole; Female; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1984 |
Depletion of glutathione in vivo as a method of improving the therapeutic ratio of misonidazole and SR 2508.
Topics: Animals; Buthionine Sulfoximine; Combined Modality Therapy; Etanidazole; Glutathione; Maleates; Methionine Sulfoximine; Mice; Mice, Inbred Strains; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents | 1984 |
The effects of radiosensitizers on intermediary metabolism in vivo.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Adenocarcinoma; Animals; Dihydroxyacetone Phosphate; Etanidazole; Glycerophosphates; Hydroxybutyrates; Lactates; Liver; Male; Mice; Mice, Inbred Strains; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Pyruvates; Radiation-Sensitizing Agents | 1984 |
The effect of timing on chemosensitization by clinical levels of SR-2508.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Drug Synergism; Drug Therapy, Combination; Etanidazole; Melphalan; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Time Factors | 1984 |
Sensitising effect of misonidazole on NHIK 1922 cells irradiated in vitro or as solid tumour in athymic nude mice.
Topics: Animals; Cell Line; Cell Survival; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Hypoxia; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Radiation-Protective Agents | 1981 |
Broad-shouldered survival curves of a human melanoma xenograft. Implications for radiation therapy in the absence and presence of misonidazole.
Topics: Animals; Humans; Melanoma; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Prognosis; Radiation-Sensitizing Agents; Transplantation, Heterologous | 1981 |
[Biological studies of proton irradiation under combination with a hypoxic cell sensitizer].
Topics: Animals; Carcinoma, Squamous Cell; Female; Mice; Mice, Inbred C3H; Mice, Inbred ICR; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Protons; Radiotherapy, High-Energy; Skin Neoplasms | 1982 |
Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.
Topics: Amifostine; Animals; Cell Division; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Fibrosarcoma; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Organothiophosphorus Compounds; Radiation Tolerance; Sarcoma, Experimental | 1983 |
Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
Topics: Amifostine; Animals; Cyclophosphamide; Drug Interactions; Drug Therapy, Combination; Extremities; Female; Fibrosarcoma; Lung Neoplasms; Male; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Organothiophosphorus Compounds; Time Factors | 1983 |
Radioprotection combined with hypoxic sensitization during radiotherapy of a solid murine tumor.
Topics: Amifostine; Animals; Cell Line; Dose-Response Relationship, Drug; Drug Interactions; Female; Mice; Mice, Inbred BALB C; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Organothiophosphorus Compounds; Oxygen; Radiotherapy Dosage; Statistics as Topic | 1983 |
Thiol reactive nitroimidazoles: radiosensitization studies in vitro and in vivo.
Topics: Animals; Cells, Cultured; Combined Modality Therapy; Cricetinae; Cricetulus; Dithiothreitol; Glutathione; Mice; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents | 1984 |
SR-2508: a 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use.
Topics: Animals; Carcinoma; Cell Line; Central Nervous System; Cricetinae; Dogs; Etanidazole; Female; In Vitro Techniques; Lipid Metabolism; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental; X-Rays | 1981 |
Preclinical pharmacokinetics of benznidazole.
Topics: Animals; Antineoplastic Agents; Brain; Chromatography, High Pressure Liquid; Dogs; Drug Evaluation, Preclinical; Female; Kinetics; Liver; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Nitroimidazoles; Pharmaceutical Vehicles; Sheep | 1984 |
The effect of prolonged high dose misonidazole on tumor response to radiation.
Topics: Animals; Combined Modality Therapy; Dose-Response Relationship, Radiation; Mice; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Time Factors | 1984 |
Potentiation of cyclophosphamide cytotoxicity in vivo: a study with misonidazole and fifteen other 1-substituted 2-nitroimidazoles.
Topics: Animals; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Lung Neoplasms; Melanoma; Mice; Mice, Inbred C57BL; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Time Factors | 1984 |
Enhancement of misonidazole radiosensitization by buthionine sulphoximine.
Topics: Animals; Buthionine Sulfoximine; Combined Modality Therapy; Dose-Response Relationship, Radiation; Drug Synergism; Glutathione; Methionine Sulfoximine; Mice; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Skin | 1984 |
Electron-affinic compounds for labelling hypoxic cells: the synthesis and characterization of 1-[2-(2-iodophenoxy)-ethyl]-2-nitroimidazole.
Topics: Animals; Male; Mice; Neoplasms; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radionuclide Imaging; Tissue Distribution | 1984 |
The labelling of EMT-6 tumours in BALB/C mice with 14C-misonidazole.
Topics: Animals; Autoradiography; Carbon Radioisotopes; Female; Injections, Intraperitoneal; Mice; Mice, Inbred BALB C; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Oxygen Consumption; Time Factors; Tissue Distribution | 1983 |
Misonidazole neurotoxicity in mice decreased by administration with pyridoxine.
Topics: Animals; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Interactions; Female; In Vitro Techniques; Kinetics; Mice; Mice, Inbred BALB C; Misonidazole; Neoplasms, Experimental; Nervous System; Nitroimidazoles; Pyridoxine; Schiff Bases; Time Factors | 1983 |
Effect of partition coefficient on the ability of nitroimidazoles to enhance the cytotoxicity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
Topics: Animals; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Hematopoietic Stem Cells; Injections, Intraperitoneal; Lomustine; Male; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Nitroimidazoles; Nitrosourea Compounds; Solubility; Spermatogonia | 1983 |
Effect of the nitroimidazole Ro 03-8799 on the activity of chemotherapeutic agents against a murine tumour in vivo.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Nitroimidazoles; Tumor Stem Cell Assay | 1984 |
Enhancement of nitrosourea cytotoxicity by misonidazole in vitro: correlation with carbamoylating potential.
Topics: Alkylating Agents; Animals; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Nitrosourea Compounds; Oxygen; Structure-Activity Relationship | 1984 |
An investigation of the possibility of chemosensitization by clinically achievable concentrations of misonidazole.
Topics: Animals; Antineoplastic Agents; Cell Division; Drug Therapy, Combination; Female; Male; Mice; Mice, Inbred C3H; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Oxygen | 1983 |
Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.
Topics: Animals; Blood Proteins; Cell Line; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Interactions; Female; Half-Life; Kinetics; Lomustine; Male; Mice; Mice, Inbred Strains; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Nitrosourea Compounds | 1983 |
Regional [14C]misonidazole distribution in experimental RT-9 brain tumors.
Topics: Animals; Autoradiography; Brain Neoplasms; Cerebrovascular Circulation; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Rats; Rats, Inbred F344; Regional Blood Flow; Tissue Distribution | 1983 |
In situ drug delivery.
Topics: Animals; Capillaries; Carmustine; Half-Life; Misonidazole; Models, Biological; Neoplasms, Experimental; Nitroimidazoles; Rats | 1980 |
Increased enhancement of tumour response to X-rays and high-LET neon ions by desmethylmisonidazole relative to misonidazole.
Topics: Animals; Dose-Response Relationship, Radiation; Energy Transfer; Misonidazole; Neon; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Rats; Rhabdomyosarcoma; X-Rays | 1982 |
Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Carmustine; Cell Line; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Melanoma; Melphalan; Mice; Mice, Inbred CBA; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Transplantation, Heterologous | 1982 |
Binding of 14C-misonidazole to hypoxic cells in V79 spheroids.
Topics: Autoradiography; Binding Sites; Cells, Cultured; Dose-Response Relationship, Drug; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Time Factors | 1982 |
Bromomisonidazole: synthesis and characterization of a new radiosensitizer.
Topics: Animals; Cell Survival; Dose-Response Relationship, Radiation; Female; Half-Life; Injections, Intraperitoneal; Injections, Intravenous; Lethal Dose 50; Male; Mice; Mice, Inbred Strains; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Tissue Distribution | 1982 |
Potentiation of melphalan activity against a murine tumour by nitroimidazole compounds.
Topics: Animals; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Male; Melphalan; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Nitroimidazoles | 1982 |
Effect of hyperthermia and misonidazole on the radiosensitivity of a transplantable murine tumor: influence of factors modifying the fraction of hypoxic cells.
Topics: Anesthesia; Animals; Dose-Response Relationship, Radiation; Hot Temperature; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation Tolerance | 1982 |
A new approach to the use of misonidazole as a radiosensitizer of hypoxic tumour cells.
Topics: Animals; Cell Survival; Dose-Response Relationship, Radiation; Humans; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiotherapy Dosage; Urinary Bladder Neoplasms | 1982 |
[Enhancement of MeCCNU potency (chemosensitization) by misonidazole in a human melanoma xenograft system].
Topics: Animals; Cell Line; Drug Interactions; Female; Humans; Melanoma; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Nitrosourea Compounds; Semustine | 1982 |
Effects of misonidazole on tumor cell radiation sensitivity and potentially lethal damage repair in vivo and in vitro.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Female; Male; Mice; Mice, Inbred Strains; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Radiation Tolerance; Time Factors | 1981 |
Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.
Topics: Animals; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Hematopoietic Stem Cells; Lomustine; Male; Mice; Mice, Inbred Strains; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Nitrosourea Compounds; Spermatogonia; Time Factors | 1982 |
Enhanced cell killing in lewis lung carcinoma and a human pancreatic-carcinoma xenograft by the combination of cytotoxic drugs and misonidazole.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Survival; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Pancreatic Neoplasms; Transplantation, Heterologous | 1981 |
Influence of misonidazole on the radiosensitivity of transplantable transitional cell bladder carcinoma in mice.
Topics: Animals; Carcinoma, Transitional Cell; Dose-Response Relationship, Radiation; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Prognosis; Radiation-Sensitizing Agents; Urinary Bladder Neoplasms | 1981 |
Effects of misonidazole, irradiation and hyperthermia on lysosomal enzyme activity in mouse tumours.
Topics: Acid Phosphatase; Animals; Body Temperature; Cell Membrane Permeability; Glucuronidase; Hot Temperature; Lysosomes; Mice; Mice, Inbred C3H; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Time Factors | 1981 |
Mechanism of misonidazole-linked cytotoxicity and altered radiation response: role of cellular thiols.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Radiation Tolerance; Sulfhydryl Compounds | 1981 |
Interactions between misonidazole and hyperthermia in EMT6 spheroids.
Topics: Cell Survival; Cells, Cultured; Hot Temperature; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Time Factors | 1981 |
Is tumour radiosensitization by misonidazole a general phenomenon?
Topics: Animals; Carcinoma; Cell Line; Dose-Response Relationship, Radiation; Male; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation Tolerance; Sarcoma, Experimental; Time Factors | 1980 |
Multiple daily fractionation (MDF) radiotherapy in association with hyperthermia and/or misonidazole: experimental and clinical results.
Topics: Animals; Drug Administration Schedule; Head and Neck Neoplasms; Humans; Hyperthermia, Induced; Lymphatic Metastasis; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Radiation Dosage; Radiotherapy; Time Factors | 1980 |
Effect of acute and chronic misonidazole administration on peripheral-nerve electrophysiology in mice.
Topics: Animals; Drug Administration Schedule; Female; Mice; Misonidazole; Neoplasms, Experimental; Neural Conduction; Nitroimidazoles; Sural Nerve; Tibial Nerve | 1980 |
Effects of local hyperthermia on the pharmacokinetics of misonidazole in the anaesthetized mouse.
Topics: Abdomen; Anesthesia; Animals; Drug Administration Schedule; Drug Interactions; Half-Life; Hindlimb; Hot Temperature; Male; Mice; Mice, Inbred BALB C; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Pentobarbital; Transplantation, Homologous | 1980 |
Cytotoxicity of hypoxic cell sensitizers in multicell spheroids.
Topics: Animals; Autoradiography; Cell Count; Cell Cycle; Cells, Cultured; Dose-Response Relationship, Drug; Doxorubicin; Kinetics; Mice; Neoplasms, Experimental; Nitroimidazoles; Oxygen | 1980 |
Effect of combined misonidazole and d(50)-Be neutrons on a human melanoma transplanted into nude mice.
Topics: Animals; Cell Line; Cell Survival; DNA Repair; Fast Neutrons; Half-Life; Humans; Injections, Intraperitoneal; Melanoma; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Neutrons; Nitroimidazoles; Radiotherapy Dosage; Time Factors; Transplantation, Heterologous | 1980 |
Testing of hypoxic cell radiosensitizers in vivo.
Topics: Animals; Cell Survival; Dose-Response Relationship, Drug; Humans; Hypoxia; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents | 1980 |
The optimum time for irradiation relative to tumour concentration of hypoxic cell sensitizers.
Topics: Animals; Cell Survival; Kinetics; Metronidazole; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents | 1980 |
Dose-dependence and related studies on the pharmacokinetics of misonidazole and desmethylmisonidazole in mice.
Topics: Animals; Biological Availability; Body Temperature; Dose-Response Relationship, Drug; Female; Half-Life; Kinetics; Male; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Phenobarbital; Premedication; Sex Factors; Skin Neoplasms | 1980 |
Cytotoxic and radiosensitizing effects of misonidazole on hematopoiesis in normal and tumor-bearing mice.
Topics: Animals; Colony-Forming Units Assay; Dose-Response Relationship, Radiation; Hematopoiesis; Hematopoietic Stem Cells; Hypoxia; Lung Neoplasms; Male; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles | 1980 |
Enhancement of antitumor activity of alkylating agents by the radiation sensitizer misonidazole.
Topics: Alkylating Agents; Animals; Aziridines; Benzoquinones; Cyclohexenes; Cyclophosphamide; Drug Therapy, Combination; Female; Melphalan; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Quinones; Semustine | 1980 |
Development of F-18-labeled fluoroerythronitroimidazole as a PET agent for imaging tumor hypoxia.
Topics: Animals; Autoradiography; Cell Hypoxia; Contrast Media; Female; Fluorine Radioisotopes; Male; Mammary Neoplasms, Experimental; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Rabbits; Rats; Rats, Inbred F344; Tissue Distribution; Tomography, Emission-Computed | 1995 |
Combined cytokinesis-block micronucleus and chromosomal aberration assay for the evaluation of radiosensitizers at low radiation doses.
Topics: Aerobiosis; Animals; Cell Line; Chromosome Aberrations; Dose-Response Relationship, Radiation; Etanidazole; Female; Mice; Mice, Inbred BALB C; Micronucleus Tests; Mutagenicity Tests; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents | 1994 |
Metabolic studies and neurotoxicity in tumors and brain of mice after hypoxic cell sensitizers.
Topics: Adenosine Triphosphate; Animals; Brain; Etanidazole; Glucose; Male; Mice; Mice, Inbred C57BL; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Nucleosides; Radiation-Sensitizing Agents | 1994 |
ELISA quantification of CCI-103F binding in canine tumors prior to and during irradiation.
Topics: Animals; Cell Hypoxia; Dogs; Enzyme-Linked Immunosorbent Assay; Neoplasms, Experimental; Nitroimidazoles | 1994 |
Relationship between the melanin content of a human melanoma cell line and its radiosensitivity and uptake of pimonidazole.
Topics: Animals; Autoradiography; Cell Line; Etanidazole; Humans; Melanins; Melanoma; Mice; Mice, Nude; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1993 |
Radiosensitization by a new potent nucleoside analog: 1-(1',3',4'-trihydroxy-2'-butoxy)methyl-2-nitroimidazole(RP-343).
Topics: Animals; Cell Hypoxia; Cell Survival; Dogs; Dose-Response Relationship, Drug; Etanidazole; Female; In Vitro Techniques; Injections, Intravenous; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Neoplasms, Experimental; Nitroimidazoles; Nucleosides; Radiation-Sensitizing Agents | 1993 |
Simultaneous triple staining for hypoxia, proliferation, and DNA content in murine tumours.
Topics: Animals; Bromodeoxyuridine; Cell Division; Cell Hypoxia; DNA, Neoplasm; Flow Cytometry; Immunohistochemistry; Male; Mice; Mice, Inbred CBA; Neoplasms, Experimental; Nitroimidazoles; Predictive Value of Tests; S Phase; Staining and Labeling; Theophylline; Tumor Cells, Cultured | 1995 |
Comparison of in vivo efficacy of hypoxic cytotoxin tirapazamine and hypoxic cell radiosensitizer KU-2285 in combination with single and fractionated irradiation.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Neoplasms, Experimental; Nitroimidazoles; Radiotherapy Dosage; Tirapazamine; Triazines | 1996 |
In vitro and in vivo evaluation of a technetium-99m-labeled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxia.
Topics: Animals; Cell Hypoxia; CHO Cells; Cricetinae; Drug Evaluation, Preclinical; In Vitro Techniques; Male; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Organotechnetium Compounds; Oxygen; Radionuclide Imaging; Technetium; Tissue Distribution; Tumor Cells, Cultured | 1996 |
Prediction of tumour hypoxia and radioresistance with nuclear medicine markers.
Topics: Animals; Cell Hypoxia; Mice; Mice, SCID; Neoplasms, Experimental; Nitroimidazoles; Radiation Tolerance; Rats; Tomography, Emission-Computed, Single-Photon | 1996 |
Preclinical evaluation of the fluorinated 2-nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554) as a probe for the measurement of tumor hypoxia.
Topics: Animals; Carbon Dioxide; Cell Hypoxia; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; Female; Fluorine; Hydralazine; Injections, Intraperitoneal; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Reproducibility of Results | 1997 |
Enhancement of bioreductive drug toxicity in murine tumours by inhibition of the activity of nitric oxide synthase.
Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Cell Survival; Drug Synergism; Enzyme Inhibitors; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Nitric Oxide Synthase; Nitroarginine; Nitroimidazoles | 1997 |
Cell cycle distribution of hypoxia and progression of hypoxic tumour cells in vivo.
Topics: Adenocarcinoma; Animals; Bromodeoxyuridine; Cell Cycle; Cell Division; DNA, Neoplasm; Flow Cytometry; Hypoxia; Mice; Neoplasms, Experimental; Nitroimidazoles; Sarcoma, Experimental; Theophylline | 1998 |
TX-1877: design, synthesis, and biological activities as a BRM-functional hypoxic cell radiosensitizer.
Topics: Animals; Cell Hypoxia; Drug Design; Female; Immunologic Factors; Lung Neoplasms; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents | 1998 |
Synthesis and characterization of lipophilic 1-[18F]fluoroalkyl-2-nitroimidazoles for imaging hypoxia.
Topics: Animals; Brain; Female; Fluorine Radioisotopes; Hypoxia; Imidazoles; Male; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Nitro Compounds; Nitroimidazoles; Radionuclide Imaging; Rats; Rats, Wistar; Solubility; Tissue Distribution | 1999 |
BRU59-21, a second-generation 99mTc-labeled 2-nitroimidazole for imaging hypoxia in tumors.
Topics: Animals; Cell Hypoxia; CHO Cells; Cricetinae; Female; Imidazoles; Male; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution | 2000 |
Synthesis, radiolabeling, and biodistribution of putative metabolites of iodoazomycin arabinoside.
Topics: Animals; Injections, Intravenous; Iodine Radioisotopes; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Nitroimidazoles; Radionuclide Imaging; Tissue Distribution | 2000 |
Depletion of tumor oxygenation during photodynamic therapy: detection by the hypoxia marker EF3 [2-(2-nitroimidazol-1[H]-yl)-N-(3,3,3-trifluoropropyl)acetamide ].
Topics: Animals; Cell Separation; Fibrosarcoma; Flow Cytometry; Mice; Microscopy, Fluorescence; Molecular Probes; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Nitroimidazoles; Oxygen Consumption; Photochemotherapy; Tumor Cells, Cultured | 2000 |
Estimation of oxygen distribution in RIF-1 tumors by diffusion model-based interpretation of pimonidazole hypoxia and eppendorf measurements.
Topics: Animals; Cell Hypoxia; Data Interpretation, Statistical; Diffusion; Female; Fibrosarcoma; Kinetics; Mice; Models, Biological; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Nitroimidazoles; Oxygen; Oxygen Consumption; Partial Pressure; Radiation-Sensitizing Agents; Staining and Labeling | 2001 |
Synthesis and evaluation of 4-bromo-1-(3-[18F]fluoropropyl)-2-nitroimidazole with a low energy LUMO orbital designed as brain hypoxia-targeting imaging agent.
Topics: Animals; Biotransformation; Chemical Phenomena; Chemistry, Physical; CHO Cells; Cricetinae; Electrons; Fluorine Radioisotopes; Hypoxia, Brain; Lipids; Mice; Mice, Inbred C3H; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Tissue Distribution | 2002 |
Combined use of radioprotective and radiosensitizing drugs in experimental radiotherapy.
Topics: Amifostine; Animals; Cell Line; Cell Survival; Dose-Response Relationship, Radiation; Drug Therapy, Combination; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Nitroimidazoles; Organothiophosphorus Compounds; Radiation-Protective Agents; Radiation-Sensitizing Agents; Time Factors | 1977 |
The application in radiation therapy of substances which modify cellular radiation response.
Topics: Amifostine; Animals; Drug Evaluation; Drug Therapy, Combination; Humans; Metronidazole; Neoplasms; Neoplasms, Experimental; Nitroimidazoles; Oxygen Consumption; Radiation-Protective Agents; Radiation-Sensitizing Agents; Radiotherapy Dosage | 1977 |
Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer.
Topics: Animals; Female; Fibrosarcoma; Male; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Osteosarcoma; Oxygen; Radiation-Sensitizing Agents; Time Factors; Transplantation, Isogeneic | 1978 |
The hyperthermic potentiation of the cytotoxic effect of misonidazole on the EMT6 mouse tumour: relevance of in vitro measurement of in vivo effect.
Topics: Animals; Cell Survival; Hot Temperature; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Nitroimidazoles; Time Factors | 1978 |
In vivo evaluation of the radiosensitizing and cytotoxic properties of newly synthesized electron-affinic drugs.
Topics: Animals; Cell Survival; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Nitroimidazoles; Octanols; Radiation-Sensitizing Agents; Solubility; Time Factors | 1978 |
Influence of tumour size on radiosensitization by misonidazole.
Topics: Animals; Cell Survival; Lung Neoplasms; Melanoma; Mice; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1978 |
The effect of misonidazole on the radiation response of clonogenic human pancreatic carcinoma cells.
Topics: Animals; Cell Survival; Humans; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Pancreatic Neoplasms; Radiation-Sensitizing Agents; Time Factors; Transplantation, Heterologous | 1978 |
Radiosensitization by misonidazole (Ro-07-0582) of fractionated X-rays in a murine tumour.
Topics: Animals; Mice; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Radiotherapy Dosage; Skin | 1978 |
Sensitization of mouse tumours using fractionated X-irradiation.
Topics: Animals; Mice; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Radiotherapy Dosage | 1978 |
Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro-07-0582) in C57 mice.
Topics: Animals; Cell Survival; Guinea Pigs; Lung Neoplasms; Mice; Mice, Inbred C57BL; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Tissue Distribution | 1979 |
Radiosensitizing effect of misonidazole in fractionated gamma-ray treatment of a human malignant melanoma grown in athymic nude mice.
Topics: Animals; Gamma Rays; Humans; Male; Melanoma; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Radiotherapy Dosage; Time Factors; Transplantation, Heterologous | 1979 |
Influence of misonidazole on the radiosensitivity of a human melanoma in nude mice: time-dependent increase in surviving fraction.
Topics: Animals; Cell Survival; Female; Humans; Hypoxia; In Vitro Techniques; Melanoma; Mice; Mice, Nude; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Time Factors | 1979 |
Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours.
Topics: Animals; Female; Half-Life; Kidney; Ligation; Mice; Mice, Inbred BALB C; Misonidazole; Neoplasms, Experimental; Nephrectomy; Nitroimidazoles; Radiation-Sensitizing Agents | 1979 |
Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of phenytoin on the pharmacokinetics and toxicity of misonidazole in mice.
Topics: Animals; Body Temperature; Body Weight; Brain; Drug Interactions; Half-Life; Lethal Dose 50; Liver; Male; Mice; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Phenobarbital; Phenytoin; Sleep; Transplantation, Homologous | 1979 |
Response of the solid Guerin epitheliomas of rats to fractionated irradiation and a new 4-nitroimidazole.
Topics: Animals; Carcinoma, Squamous Cell; Male; Metronidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Rats; Rats, Inbred Strains; Time Factors; Transplantation, Homologous | 1979 |
Cytotoxicity of misonidazole in vivo under conditions of prolonged contact of drug with the tumour cells.
Topics: Animals; Cell Survival; Half-Life; Mice; Mice, Inbred BALB C; Misonidazole; Neoplasms, Experimental; Nephrectomy; Nitroimidazoles; Time Factors | 1979 |
Hypoxic cell radiosensitizers--chemical aspects and in vitro models.
Topics: Animals; Cell Line; Chemical Phenomena; Chemistry; Cricetinae; Cricetulus; Hypoxia; Lung; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Structure-Activity Relationship | 1978 |
Cytotoxic effects of the hypoxic cell radiosensitizer Ro 7-0582 to tumor cells in vivo.
Topics: Animals; Dose-Response Relationship, Radiation; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Time Factors | 1977 |
The radiosensitizing effect of metronidazole and misonidazole (Ro-07-0582) on a human malignant melanoma grown in the athymic mutant nude mouse.
Topics: Animals; Humans; Melanoma; Metronidazole; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Radiation Dosage; Radiation-Sensitizing Agents; Time Factors | 1978 |
Cytotoxicity and radiosensitization in mouse and man.
Topics: Animals; Cell Survival; Humans; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Skin Neoplasms | 1978 |
Effects of dimethyl sulfoxide and hypoxic cell radiosensitizers on the radiation response of the KHT murine tumor in vivo.
Topics: Animals; Cell Survival; Dimethyl Sulfoxide; Male; Metronidazole; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Protective Agents; Radiation-Sensitizing Agents; Sarcoma | 1977 |
Radiosensitization of hypoxic tumor cells by simultaneous administration of hyperthermia and nitroimidazoles.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Survival; Deoxyuridine; Female; Hyperthermia, Induced; Hypoxia; Leukemia L1210; Metronidazole; Mice; Mice, Inbred Strains; Neoplasms; Neoplasms, Experimental; Nitroimidazoles; Radiation Tolerance; Radiation-Sensitizing Agents; Sarcoma | 1977 |
Radiosensitizing and cytocidal effects on hypoxic cells of RO-07-0582, and repair of x-ray injury, in an experimental mouse tumour.
Topics: Animals; Carcinoma, Squamous Cell; Hypoxia; Male; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Skin Neoplasms; Transplantation, Homologous | 1977 |
Hypoxic cell radiosensitizers and local control by X-ray of a transplanted tumour in mice.
Topics: Animals; Hypoxia; Metronidazole; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Nitrofurans; Nitroimidazoles; Radiation-Sensitizing Agents; Radiotherapy Dosage; Razoxane; Regeneration; Transplantation, Homologous | 1977 |
Further investigations of the effects of the hypoxic-cell radiosensitizer, Ro-07-0582, on local control of a mouse tumour.
Topics: Animals; Female; Guinea Pigs; Neoplasm Metastasis; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Time Factors | 1977 |
Radiosensitizers of hypoxic cells in solid tumors.
Topics: Animals; Cells, Cultured; Cricetinae; Dose-Response Relationship, Drug; Fast Neutrons; Mammary Neoplasms, Experimental; Metronidazole; Mice; Neoplasm Metastasis; Neoplasms; Neoplasms, Experimental; Nitroimidazoles; Oxygen Consumption; Radiation-Sensitizing Agents; Radiotherapy Dosage | 1976 |
Proceedings: Radiosensitization of hypoxic cells in solid tumours in mice.
Topics: Animals; Fast Neutrons; Guinea Pigs; Humans; Hypoxia; Metronidazole; Mice; Nausea; Neoplasms, Experimental; Nitroimidazoles; Oxygen Consumption; Rabbits; Radiation-Sensitizing Agents; Rats | 1975 |
Selective radiosensitization of the hypoxic cells of mouse tumors with the nitroimidazoles metronidazole and Ro 7-0582.
Topics: Animals; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Metronidazole; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; X-Ray Therapy | 1975 |
Radioiodinated 1-(2-fluoro-4-iodo-2,4-dideoxy-beta-L-xylopyranosyl)-2-nitroimidazole: a novel probe for the noninvasive assessment of tumor hypoxia.
Topics: Animals; Cell Hypoxia; Dideoxynucleosides; Iodine Radioisotopes; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Nitroimidazoles; Radionuclide Imaging; Tissue Distribution | 1992 |
[Radiosensitizing effect of a 2-nitroimidazole hydroxamate (KIN-804) to murine tumors].
Topics: Animals; Hydroxamic Acids; Lethal Dose 50; Male; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents | 1992 |
Radiosensitization by 2-nitroimidazole nucleoside analog RP-170: radiosensitizing effects under both intravenous and oral administration.
Topics: Administration, Oral; Animals; Combined Modality Therapy; Etanidazole; Female; Injections, Intravenous; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Nucleosides; Radiation-Sensitizing Agents; Rats; Rats, Inbred Strains | 1992 |
Modification of alkylating agent induced cell kill by 2-nitroimidazoles in unclamped and clamped SC 9L tumors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Hypoxia; Cell Survival; Cyclophosphamide; Etanidazole; Ifosfamide; Male; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Rats; Rats, Inbred F344 | 1992 |
Bioreductive drugs as post-irradiation sensitizers: comparison of dual function agents with SR 4233 and the mitomycin C analogue EO9.
Topics: Animals; Antineoplastic Agents; Aziridines; Cell Hypoxia; Cell Survival; Combined Modality Therapy; Dose-Response Relationship, Drug; Indolequinones; Indoles; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Prodrugs; Tirapazamine; Triazines | 1992 |
Tumor blood flow changes induced by chemical modifiers of radiation response.
Topics: Animals; Antineoplastic Agents; Blood Flow Velocity; Cisplatin; Doxorubicin; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents | 1992 |
NLA-1: a 2-nitroimidazole radiosensitizer targeted to DNA by intercalation.
Topics: Aminoacridines; Animals; Cell Hypoxia; Cell Line; Combined Modality Therapy; DNA; DNA, Neoplasm; Intercalating Agents; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents | 1992 |
Fluorine modification of nitroazole radiosensitizers for the enhancement of sensitizing activity with lowering toxicity: a pharmacokinetic characterization.
Topics: Animals; Brain; Combined Modality Therapy; Female; Lethal Dose 50; Mice; Mice, Inbred C3H; Mice, Inbred ICR; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Triazoles | 1992 |
A comparison of radiosensitization by etanidazole and pimonidazole in mouse tumors.
Topics: Animals; Cell Survival; Combined Modality Therapy; Etanidazole; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents | 1991 |
A fluorinated 2-nitroimidazole, KU-2285, as a new hypoxic cell radiosensitizer.
Topics: Animals; Combined Modality Therapy; Dose-Response Relationship, Radiation; Etanidazole; Female; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents | 1991 |
Radioiodinated 1-(5-iodo-5-deoxy-beta-D-arabinofuranosyl)-2-nitroimidazole (iodoazomycin arabinoside: IAZA): a novel marker of tissue hypoxia.
Topics: Animals; Cell Hypoxia; Iodine Radioisotopes; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Tissue Distribution | 1991 |
Dynamic measurements of hexafluoromisonidazole (CCI-103F) retention in mouse tumours by 1H/19F magnetic resonance spectroscopy.
Topics: Animals; Cell Hypoxia; Injections, Intraperitoneal; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles | 1990 |
Flow cytometric evaluation of hypoxic cells in solid experimental tumours using fluorescence immunodetection.
Topics: Animals; Cell Hypoxia; Cricetinae; Cricetulus; Flow Cytometry; Fluorescent Antibody Technique; Neoplasms, Experimental; Nitroimidazoles; Sarcoma, Experimental; Theophylline | 1991 |
Prediction of tumor radiosensitivity by hexafluoromisonidazole retention monitored by [1H]/[19F] magnetic resonance spectroscopy.
Topics: Animals; Cell Hypoxia; Cell Survival; Gamma Rays; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Nitroimidazoles; Radiation Tolerance; Radiography; Radionuclide Imaging; Tumor Cells, Cultured | 1991 |
Chemosensitization of the nitrosoureas by 2-nitroimidazoles in the subcutaneous 9L tumor model: pharmacokinetic and structure-activity considerations.
Topics: Animals; Carmustine; Drug Synergism; Etanidazole; Lomustine; Male; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Nitrosourea Compounds; Rats; Rats, Inbred F344; Structure-Activity Relationship | 1990 |
Tumour radiosensitization by clofibrate and its analogs: possible mechanisms.
Topics: Animals; Bezafibrate; Clofibrate; Combined Modality Therapy; Etanidazole; Female; Hypoxia; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Regional Blood Flow | 1990 |
Experimental intra-arterial administration of SR-2508 in the rabbit V2 carcinoma model.
Topics: Animals; Etanidazole; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Neoplasms, Experimental; Nitroimidazoles; Rabbits; Radiation-Sensitizing Agents | 1989 |
Ro 03-8799: preferential relative uptake in human tumor xenografts compared to a murine tumor: comparison with SR-2508.
Topics: Animals; Cell Line; Etanidazole; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Transplantation, Heterologous | 1989 |
The effect of glutathione (GSH) depletion in vivo by buthionine sulfoximine (BSO) on the radiosensitization of SR 2508.
Topics: Animals; Buthionine Sulfoximine; Etanidazole; Glutathione; Methionine Sulfoximine; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Radiotherapy Dosage | 1989 |
Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170).
Topics: Animals; Cell Survival; Combined Modality Therapy; Etanidazole; In Vitro Techniques; Mice; Mice, Inbred Strains; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Nucleosides; Radiation-Sensitizing Agents | 1989 |
Characteristics of fluorinated nitroazoles as hypoxic cell radiosensitizers.
Topics: Animals; Cell Survival; Combined Modality Therapy; Hydrocarbons, Fluorinated; In Vitro Techniques; Lethal Dose 50; Mice; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Triazoles | 1989 |
Demonstration of tumor-selective retention of fluorinated nitroimidazole probes by 19F magnetic resonance spectroscopy in vivo.
Topics: Animals; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1989 |
Stimulation by localized tumor hyperthermia of reductive bioactivation of 2-nitroimidazole benznidazole in mice.
Topics: Amines; Animals; Hyperthermia, Induced; Liver; Male; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Nitroimidazoles; Oxidation-Reduction | 1989 |
Effects on intermediary metabolism in mouse tissues by Ro-03-8799.
Topics: Adenocarcinoma; Animals; Body Temperature; Brain; Glucose; Glucose-6-Phosphatase; Ketone Bodies; Lipid Metabolism; Liver; Liver Glycogen; Male; Mice; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Time Factors | 1987 |
Influence of misonidazole, SR-2508, RSU-1069 and WR-2721 on spontaneous metastases in C57BL mice.
Topics: Amifostine; Animals; Etanidazole; Lung Neoplasms; Male; Melanoma; Mice; Mice, Inbred C57BL; Misonidazole; Neoplasm Metastasis; Neoplasms, Experimental; Nitroimidazoles; Radiation-Protective Agents; Radiation-Sensitizing Agents | 1988 |
Sensitization by SR-2508 plus Ro 03-8799.
Topics: Animals; Combined Modality Therapy; Drug Combinations; Etanidazole; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents | 1986 |
SR-2508 plus buthionine sulfoximine or SR-2508 alone: effects on the radiation response and the glutathione content of a human tumor xenograft.
Topics: Buthionine Sulfoximine; Cell Survival; Cysteine; Etanidazole; Glutathione; Humans; Methionine Sulfoximine; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents | 1987 |
Additivity of radiosensitization by the combination of SR 2508 (etanidazole) and Ro 03-8799 (pimonidazole) in a murine tumor system.
Topics: Animals; Cell Survival; Drug Therapy, Combination; Etanidazole; Female; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents | 1988 |
[Development of new hypoxic cell radiosensitizer in Japan].
Topics: Animals; Dogs; Drug Evaluation, Preclinical; Etanidazole; Hydroxamic Acids; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents | 1988 |
Nitroimidazole bioreductive metabolism. Quantitation and characterisation of mouse tissue benznidazole nitroreductases in vivo and in vitro.
Topics: Aldehyde Oxidase; Aldehyde Oxidoreductases; Animals; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Cytosol; Kidney; Kinetics; Liver; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Microsomes, Liver; NADP; NADPH-Ferrihemoprotein Reductase; Neoplasms, Experimental; Nitroimidazoles; Nitroreductases; Oxidoreductases | 1987 |
[Enhancement of the effect of radiotherapy of Guerin's carcinoma by tinidazole].
Topics: Animals; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Rats; Tinidazole | 1987 |
Radiosensitization in vitro and in vivo by 3-nitrotriazoles.
Topics: Animals; Combined Modality Therapy; Cricetinae; Female; In Vitro Techniques; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Nitro Compounds; Nitroimidazoles; Radiation-Sensitizing Agents; Triazoles | 1986 |
Covalent binding of a fluorinated 2-nitroimidazole to EMT-6 tumors in Balb/C mice: detection by F-19 nuclear magnetic resonance at 2.35 T.
Topics: Animals; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Oxygen | 1986 |
Radiosensitization, pharmacokinetics, and toxicity of a 2-nitroimidazole nucleoside (RA-263).
Topics: Animals; Cell Line; Cell Survival; Cricetinae; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; In Vitro Techniques; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mutagenicity Tests; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents | 1986 |
[Radioprotective phenomena in murine tumors induced by radiosensitizers at high dose levels].
Topics: Animals; Combined Modality Therapy; Mice; Neoplasms, Experimental; Nitroimidazoles; Oxadiazoles; Radiation-Protective Agents; Radiation-Sensitizing Agents | 1986 |
Sensitization of cancer chemotherapeutic agents by nitroheterocyclics.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cell Survival; Drug Synergism; Heterocyclic Compounds; Hydroxamic Acids; Hypoxia; Lomustine; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents | 1986 |
Iodoazomycin riboside (1-(5'-iodo-5'-deoxyribofuranosyl)-2-nitroimidazole), a hypoxic cell marker. I. Synthesis and in vitro characterization.
Topics: Animals; Cell Survival; In Vitro Techniques; Iodine Radioisotopes; Mice; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1986 |
Binding of misonidazole to hypoxic cells in monolayer and spheroid culture: evidence that a side-chain label is bound as efficiently as a ring label.
Topics: Animals; Carbon Radioisotopes; Cell Aggregation; Cells, Cultured; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Structure-Activity Relationship; Tritium | 1985 |
Regional measurements of [14C]misonidazole distribution and blood flow in subcutaneous RT-9 experimental tumors.
Topics: Animals; Carbon Radioisotopes; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Rats; Regional Blood Flow; Tissue Distribution | 1985 |
Comparison of binding of [3H]misonidazole and [14C]misonidazole in multicell spheroids.
Topics: Animals; Carbon Radioisotopes; In Vitro Techniques; Misonidazole; Models, Biological; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Tritium | 1985 |
Further characterization of 4-bromomisonidazole as a potential detector of hypoxic cells.
Topics: Animals; Autoradiography; Carbon Radioisotopes; Misonidazole; Models, Biological; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1985 |
Changes in misonidazole binding with hypoxic fraction in mouse tumors.
Topics: Animals; Hematocrit; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation Tolerance | 1985 |
Carcinogenicity of 5-nitrofurans, 5-nitroimidazoles, 4-nitrobenzenes, and related compounds.
Topics: Adenocarcinoma; Animals; Benzene Derivatives; Carcinogens; Chemical Phenomena; Chemistry; Diet; Female; Kidney Neoplasms; Leukemia, Experimental; Leukemia, Lymphoid; Mammary Neoplasms, Experimental; Neoplasms, Experimental; Nitrobenzenes; Nitrofurans; Nitroimidazoles; Rats | 1973 |